Evidence map›Paper›PMID 34072288›Full record

ArticleVaccines2021

Vaccine Production Process: How Much Does the General Population Know about This Topic? A Web-Based Survey.

Angela Bechini, Paolo Bonanni, Beatrice Zanella, Giulia Di Pisa, Andrea Moscadelli, Sonia Paoli, Leonardo Ancillotti, Benedetta Bonito, Sara Boccalini

Open access · goldAbstract read
In one paragraph

Article in Vaccines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Angela BechiniDepartment of Health Sciences, University of Florence, 50134 Florence, Italy.ORCID 0000-0002-6013-8779
Paolo BonanniDepartment of Health Sciences, University of Florence, 50134 Florence, Italy.ORCID 0000-0003-2875-3744
Beatrice ZanellaDepartment of Health Sciences, University of Florence, 50134 Florence, Italy.ORCID 0000-0001-6718-1932
Giulia Di PisaMedical Specialization School of Hygiene and Preventive Medicine, University of Florence, 50134 Florence, Italy.
Andrea MoscadelliMedical Specialization School of Hygiene and Preventive Medicine, University of Florence, 50134 Florence, Italy.
Sonia PaoliMedical Specialization School of Hygiene and Preventive Medicine, University of Florence, 50134 Florence, Italy.
Leonardo AncillottiDepartment of Health Sciences, University of Florence, 50134 Florence, Italy.
Benedetta BonitoDepartment of Health Sciences, University of Florence, 50134 Florence, Italy.
Sara BoccaliniDepartment of Health Sciences, University of Florence, 50134 Florence, Italy.ORCID 0000-0002-9695-7549
University of Florence · IT

Funding

GSK S.p.A 3001980298/2019
6 · The paper itself

Abstract

backgroundVaccine hesitancy has been recognized as a major global health threat by the World Health Organization. Many studies have investigated vaccine safety as a determinant for vaccine hesitancy; however, not much attention has been paid to vaccine production and quality control during the vaccine production process or whether knowledge about this topic may influence vaccine confidence. The aim of this study was to characterize the common knowledge about the vaccine production process.

methodsA freely accessible online questionnaire was developed on Google Modules and disseminated through social networks. A descriptive analysis of the collected answers was performed, and the chi-square test was used to assess significant differences for the sociodemographic characteristics of the study population (age, gender, work or education and training in the healthcare setting, minor offspring). A binary logistic regression model was performed considering these socio-demographic categories as independent variables.

resultsThe number of collected questionnaire was 135. Most of the participants (127/135, 94.1%) were aware that quality control measures are carried out during manufacturing, although some knowledge gaps emerged in specific aspects of the vaccine production process, without statistically significant differences between age groups. Working in the healthcare setting or being educated in healthcare may be considered predictors for a better understanding that more than 50% of the production time is spent on quality control (AOR = 3.43; 95% CI: 1.84-8.14,

conclusionsThis study allowed for a characterization of common knowledge about the vaccine production process. It highlighted the need to implement specific strategies to spread correct information about the vaccine production process. This study may contribute to increased confidence and trust in vaccines and vaccination among the general population.

Indexed as

hesitancyimmunizationknowledgeonline surveypharmaceutical industryquality controlsafetyvaccine manufacturing

Identifiers

PMID34072288
PMCPMC8229207
OpenAlexW3164346017

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.